Humatrope’s Impact on Metabolic Profiles in American Males with Prader-Willi Syndrome: A 3-Year Study
Reading Time: < 1 minute Introduction Prader-Willi Syndrome (PWS) is a complex genetic disorder characterized by a range of symptoms including chronic hunger, obesity, and various metabolic disturbances. The management of PWS often involves a multidisciplinary approach, with growth hormone therapy being a cornerstone of treatment. Humatrope, a recombinant human growth hormone, has been utilized to improve growth, body composition, and metabolic profiles in individuals with PWS. This article presents findings from a 3-year observational study focused on the influence of Humatrope on metabolic profiles in American males diagnosed with PWS. Study Design and Participants The study was conducted over a 3-year period, involving 50...



